- The Dish’s Weekly Biotechnology News Wrap Up – April 21, 2017Posted 4 days ago
- Glycosylation Overview and How to Control Glycosylation using In Vitro GlycoengineeringPosted 6 days ago
- A Novel Approach for Expansion of High Quality Mesenchymal Stem CellsPosted 7 days ago
- Cell Therapy Clinical Trials: Navigating the operational shift from Phase 1 to Phase 2Posted 1 week ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 14, 2017Posted 2 weeks ago
- GMP Proteins for Cell Therapy Manufacturing: Top 6 Things to KnowPosted 2 weeks ago
- Smart Cell Culture Monitoring – Transforming the way we look at cells in culturePosted 2 weeks ago
- A Primer on Primary Cells and CulturePosted 2 weeks ago
- The Importance of Resin Selection in Development of a Platform Bioprocess FilmPosted 2 weeks ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 7, 2017Posted 3 weeks ago
More Business News
Stem Cell Therapy Indications for Neurological Disorders in Phase II Clinical Trials
Stem cell therapies are being developed for several different indications. In April we reviewed...
- Posted July 10, 2014
Aastrom CEO Discusses How Recent Acquisition Strengthens Current Manufacturing Capability and Clinical Pipeline
In late April, it was announced that Aastrom had acquired Sanofi’s Cell Therapy and...
- Posted May 8, 2014
GE Healthcare Completes Acquisition of Three Thermo Fisher Scientific Business Divisions
On Monday, GE Healthcare announced completion of their acquisition of Thermo Fisher Scientific’s HyClone...
- Posted March 25, 2014
Biologics Still on Top in Best Selling Drugs of 2013
Genetic Engineering News recently published an article titled “The Top 25 Best-Selling Drugs of...
- Posted March 13, 2014
Biologics Have a Robust Pipeline According to Latest PhRMA Report
Earlier this month, the Pharmaceutical Research and Manufacturers of America released a new report...
- Posted March 21, 2013